Homecare acquisition in France

Air Liquide has just completed the acquisition of DinnoSanté, a company that specializes in medical-technical services for diabetes.

Air Liquide, number one in the European homecare market, has just completed the 100% acquisition of DinnoSanté, a company that specializes in medical-technical services for diabetes.

DinnoSanté is a French company with 90 employees which specializes in the equipment and home monitoring of patients with diabetes. It supplies nearly 2,300 chronic diabetes patients with equipment designed to facilitate their lives, including insulin pumps and glucose meters, and supporting them with personalized training and regular follow-up.

Diabetes is a major chronic illness whose development is in large part linked to changes in lifestyle as well as an aging population. In France, more than 2.5 million people are being treated for diabetes, a figure that is constantly rising. Advances in treatment technologies and the growing use of insulin pumps help to improve the quality of life of the patients by giving them greater mobility as well as greater flexibility of use.

This acquisition reinforces Air Liquide’s offer in taking charge of pathologies that are treatable at home: sleep apnea (frequent in patients with diabetes), chronic respiratory disease, etc.

Pascal Vinet, Vice-President, Healthcare World Business Line and Healthcare Operations, Air Liquide Group, commented: “This new Healthcare acquisition illustrates our development strategy which seeks to strengthen our global range of services related to homecare treatments. Health is a solid and promising growth driver for the Air Liquide Group.”

more about DinnoSanté [fr]